CCM
GOSS icon

Ciovacco Capital Management’s Gossamer Bio GOSS Stock Holding History

Ciovacco Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,204
Closed -$31.6K – 30
2025
Q4 		$31.6K Hold
10,204
– – 0.02% 27
2025
Q3 		$26.8K Buy
+10,204
New +$22.5K 0.01% 30

Other funds holding GOSS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Ciovacco Capital Management's GOSS Position: Q1 2026 in Review

Ciovacco Capital Management sold out of Gossamer Bio (GOSS) in Q1 2026, closing a stake of 10,204 shares — an estimated $31.6K sold.

Ciovacco Capital Management first reported a position in GOSS in Q3 2025 and held it in 2 quarters. The position peaked at $31.6K in Q4 2025. 185 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Ciovacco Capital Management reported no remaining Gossamer Bio position as of Q1 2026 after selling out during the quarter.
  • Ciovacco Capital Management sold 10,204 Gossamer Bio shares in Q1 2026, an estimated $31.6K.
  • Ciovacco Capital Management first reported a position in Gossamer Bio in Q3 2025 and held it in 2 quarters.
  • Ciovacco Capital Management's Gossamer Bio position peaked at $31.6K in Q4 2025.
  • 185 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Ciovacco Capital Management's 13F filing for Q1 2026, filed 11 May 2026.